Comment on: Insulinoma in tuberous sclerosis: an entity not to be missed

References

1. 1.↵
   1. Al Qahtani MS,
   2. Bojal SA,
   3. Alqarzaie AA,
   4. Alqahtani AA.

   Insulinoma in tuberous sclerosis: an entity not to be missed. Saudi Med J 2021; 42: 332–337.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Zaver HB,
   2. Alnahhal KI,
   3. Ghoz H,
   4. Paz-Fumagalli R,
   5. Raimondo M,
   6. Lukens FJ.

   Insulinoma: a recurrent pancreatic tumor amendable to computed tomography-guided ethanol-lipiodol injection. ACG Case Rep J 2021; 8: e00539.

   OpenUrl
3. 3.↵
   1. Shin JJ,
   2. Gorden P,
   3. Libutti SK.

   Insulinoma: pathophysiology, localization and management. Future Oncol 2010; 6: 229–237.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Kang MY,
   2. Yeoh J,
   3. Pondicherry A,
   4. Rahman H,
   5. Dissanayake A.

   Insulinoma and tuberous sclerosis: a possible mechanistic target of rapamycin (mTOR) pathway abnormality? J Endocr Soc 2017; 1: 1120–1123.

   OpenUrl